RILEY JENNIFER (Chief Strategy Officer) received a stock award from AVALO THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/26/2026ACC: 0002047607-26-000004
Officer· Chief Strategy Officer
Since Feb 2026
+34.20K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
34.20K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+34.20K
Price / share
—
Trade value
—
% of position
1288.1%
5/21/2026
2.65K→36.85K
Total
Net shares
+34.20K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/21/2026 | A · Award | +34.20K | — | — | 1288.1% | 2.65K | 36.85K |
| Total | +34.20K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported